Subtype
Benign Skin Epithelial Neoplasm
CI-CAN-00000546Explore in graph →
Non-malignant10 active trials
- NCIt
- C7341
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000546Explore in graph →
Clinical trials
60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05937672 | Cold Atmospheric Plasma Device Extension Study | terminated | Phase 3 | 60 | Medical University of South CarolinaOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04249115 | Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study | terminated | N/A | 175 | Pulse Biosciences, Inc.INDUSTRY | 1 | Oct 30, 2023 | clinicaltrials |
| NCT04688749 |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage(DermaSense) |
| terminated |
| — |
| 50 |
| Aristotle University Of ThessalonikiOTHER |
| 1 |
| Jul 25, 2023 |
| clinicaltrials |
| NCT01131325 | Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations(MACS1148) | terminated | Phase 4 | 3 | Novartis PharmaceuticalsINDUSTRY | 1 | May 20, 2021 | clinicaltrials |
| NCT01609530 | Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy | terminated | N/A | 31 | Trinity Health MichiganOTHER | 1 | Mar 22, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Apr 3, 2026source: clinicaltrials